Demetronium Bromide (CAS 56-94-0), also known as demecarium bromide, is a carbamate parasympathomimetic and acetylcholinesterase inhibitor used historically in ophthalmology, particularly for the treatment of glaucoma. It enhances cholinergic activity in the eye, leading to miosis (pupil constriction), improved aqueous humor outflow and reduced intraocular pressure.
The TCS INDUSTRIES LIMITED product
Demetronium Bromide 56-94-0 | Anticholinergic Pharmaceutical Intermediate Supplier
describes demecarium bromide as a glaucoma medication applied topically to the eye to manage elevated intraocular pressure. Although many commercial eye-drop formulations have been discontinued, the compound remains of interest as a pharmaceutical intermediate and reference standard in ophthalmic research and development.
Within the TCS GROUP portfolio, Demetronium Bromide is connected to other vision-care and chronic-care APIs under the
Active Pharmaceutical Ingredient
umbrella. In ophthalmology, it is conceptually related to pressure-lowering and ocular-health agents such as
a prostaglandin analog widely used to treat elevated intraocular pressure and to support eyelash-growth indications.
Because Demetronium Bromide is a potent cholinesterase inhibitor, strict controls are required during manufacturing and handling:
- Appropriate containment and personal protective equipment.
- Careful management of dust and residues.
- Robust analytical methods to monitor identity, potency and impurities.
TCS INDUSTRIES LIMITED supports customers with detailed product specifications, safety information and guidance for storage and transport. For organisations working on ophthalmic APIs and intermediates, this product can serve as part of a broader, integrated sourcing plan that also involves materials from the
category.
Whether used as an active component in compounded eye preparations (where allowed) or as a reference and synthetic intermediate in glaucoma drug research, Demetronium Bromide 56-94-0 from TCS GROUP offers a reliable, high-quality option backed by pharmaceutical-grade quality systems and technical expertise.